Health care improvement and cost reduction opportunities in hypertensive medicaid beneficiaries

Journal of Clinical Hypertension

Volumn 3, Issue 5, 2001, Pages

  Egan, B M ^a   Lackland, D T ^a   Williams, B ^a   Gunter, N ^a   Tocharoen, A ^a   Beardon, L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AFRICA; ARTICLE; CARDIOVASCULAR DISEASE; COMPLICATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; COST; EVIDENCE BASED MEDICINE; FEMALE; FINANCIAL MANAGEMENT; HEALTH; HEALTH CARE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LIFE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAID; MORBIDITY; PRACTICE GUIDELINE; PRESCRIPTION; RACE; SOCIOECONOMICS; UNITED STATES;

EID: 0034756704     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2001.00477.x     Document Type: Article

References (14)

1. Are race differences in the prevalence of hypertension explained by body mass and fat distribution? A survey in a biracial population
2. Hypertension-related morbidity and mortality in the southeastern United States
3. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
4. Hypertension initiative of South Carolina
5. Impact of nativity and race on stroke belt mortality
6. Impact of cost problems on morbidity in a hypertensive population
7. Pharmacologic treatment of hypertension among the South Carolina Medicaid population
8. Correlates of nonadherence to hypertension treatment in an inner-city minority population
9. Correlates of controlled hypertension in indigent, inner-city hypertensive patients
10. Access to hypertensive care: Effects of income, insurance, and source of care
11. Stratagies of prevention and the importance of public health and community programs
12. Overview of randomized clinical trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with congestive heart failure Collaborative Group on ACE Inhibitor Trials
13. Effect of metoprolol CR/XL in Chronic Heart Failure. Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)
14. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction